In this blog post, we’ll explore what automated clinical trial data reporting entails, why it matters, and how your organization can benefit from adopting this technology sooner rather than later.
The European Medicines Agency (EMA) recently launched new rules with its EMA Policy 0070 Step 2. This update strengthens and expands clinical trial transparency rules, protecting patient privacy and commercially confidential information.
Strong Tower Solutions is now a part of Instem
This blog examines the typical challenges of decentralized SCEs and highlights the benefits of adopting centralized, scalable alternatives.
This article emphasizes the critical role of access management in biostatistics, outlines the essential elements of a strong access management strategy, and shares best practices to help your team achieve lasting success.
This article highlights the importance of validation in biostats, breaks down the key components of an effective validation strategy, and provides best practices to set your team up for long-term success.
